Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).

van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Lok DJ, Dohmen HJ, Poortermans JC, Withagen AJ, Pasteuning WH, Brouwer J, Lie KI.

J Am Coll Cardiol. 1993 Nov 15;22(6):1564-73.

2.
3.

Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.

Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Dunselman PH, Boomsma F, Haaksma J, Lie KI.

J Am Coll Cardiol. 1995 Oct;26(4):983-90.

4.

Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.

Szabó BM, van Veldhuisen DJ, van der Burgh PH, Kruik J, Girbes AR, Lie KI.

J Card Fail. 1996 Sep;2(3):185-92.

PMID:
8891856
5.

Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.

Alicandri C, Fariello R, Boni E, Zaninelli A, Muiesan G.

J Cardiovasc Pharmacol. 1989;14 Suppl 8:S77-82.

PMID:
2483444
8.

The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.

Lieverse AG, Girbes AR, Van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Lie KI, Reitsma WD.

Eur Heart J. 1995 Jul;16(7):937-42.

PMID:
7498209
9.
10.

Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.

Cadel A, Brusoni B, Pirelli P, Osculati G, Rovati A, Fanciulli R, Carati L, Valagussa F.

Arzneimittelforschung. 1986 Feb;36(2A):376-9.

PMID:
3707653
11.
12.

Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.

López-Sendón J.

Am J Med. 1991 May 29;90(5B):43S-49S. Review.

PMID:
1675551
13.

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.

Rousseau MF, Konstam MA, Benedict CR, Donckier J, Galanti L, Melin J, Kinan D, Ahn S, Ketelslegers JM, Pouleur H.

Am J Cardiol. 1994 Mar 1;73(7):488-93.

PMID:
7908164
14.

Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.

Sher D, Licciardello L, Ferrari V, Sirtori F, Cesana B.

Arzneimittelforschung. 1991 Apr;41(4):402-9.

PMID:
1859514
15.

Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.

Cocchieri M, Alunni GF, Del Favero A, Fortunati F, Bardelli G, Capponi EA, Regi L, Boschetti E.

Cardiology. 1990;77 Suppl 5:36-42.

PMID:
2126222
17.

[Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].

Fonseca C, Gouveia R, Ceia F, Mota E, Coelho EM, Gil V, Riva E, Astorga MA, Gomes RS, Luís AS.

Rev Port Cardiol. 1992 Jun;11(6):515-23. Portuguese.

PMID:
1503784
18.

Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.

Lieverse AG, van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Reitsma WD, Lie KI, Girbes AR.

J Cardiovasc Pharmacol. 1995 Mar;25(3):361-7.

PMID:
7769799
19.

[Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].

Arcensio SR, Barretto AC, Szambock F, Mady C, Arteaga E, da Luz PL, Bellotti G, Pileggi F.

Arq Bras Cardiol. 1994 Nov;63(5):409-13. Portuguese.

PMID:
7611921
20.

Efficacy and safety of ibopamine in congestive heart failure.

van Veldhuisen DJ, Girbes AR, Crijns HJ, Smit AJ, de Graeff PA, Lie KI.

J Auton Pharmacol. 1990;10 Suppl 1:s115-21.

PMID:
1983005

Supplemental Content

Support Center